Divergent roles of nonsense-mediated RNA decay in oncovirus latency and reactivation

无义介导的RNA衰变在肿瘤病毒潜伏和重新激活中的不同作用

基本信息

  • 批准号:
    10880993
  • 负责人:
  • 金额:
    $ 12.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

Nonsense-mediated RNA Decay (NMD) is a highly conserved cellular quality control pathway that degrades many mutant or aberrantly spliced RNA transcripts. Reports in the literature have recently linked NMD processes to oncogenesis and metastasis, in complex and sometimes contradictory ways. Often considered a tumor suppressor pathway, NMD is frequently downregulated in cancers, resulting in higher expression of (sometimes mutated) oncogenes. On the other hand, some cancers appear to harness or even enhance the NMD system to degrade transcripts of tumor suppressor genes, dysregulating oncogene expression and leading to increased cancer cell proliferation. EBV is a ubiquitous human pathogen that infects more than 90% of the world’s population and is associated with cancers including lymphomas, gastric carcinoma and nasopharyngeal carcinoma. Typically, EBV persists in host B cells in a latent phase, during which time limited viral gene expression shields the virus from the host immune system. Periodically, reactivation of the lytic cycle leads to viral takeover of the host cell and production of new infectious virions, facilitating viral spread. Interestingly, some EBV RNA transcripts expressed during reactivation appear to be NMD targets. Our preliminary studies have revealed that EBV actively inhibits host cellular NMD during lytic reactivation, presumably preventing degradation of viral RNA transcripts and facilitating viral protein translation and virion production. In contrast, we find that the NMD pathway is active during the latency phase where it likely promotes cell proliferation while simultaneously preventing lytic reactivation. These two opposite modes of engagement form a sort of “yin and yang” relationship between EBV and host NMD that plays a key role in governing its biphasic infection strategy. With this project we will investigate this novel dynamic viral interface with a host system to determine the mechanistic underpinnings of EBV-NMD interactions and determine its functional impact on viral reactivation, viral latency and lymphoma cell growth and proliferation.
无义介导的RNA衰变(NMD)是一种高度保守的细胞质量控制途径,可降解许多突变或异常剪接的RNA转录物。最近的文献报道将NMD过程与肿瘤发生和转移联系起来,以复杂且有时相互矛盾的方式。NMD通常被认为是一种肿瘤抑制途径,在癌症中经常下调,导致癌基因的高表达(有时是突变)。另一方面,一些癌症似乎利用甚至增强NMD系统来降解肿瘤抑制基因的转录本,失调癌基因的表达,导致癌细胞增殖增加。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christina M O'Grady其他文献

Christina M O'Grady的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christina M O'Grady', 18)}}的其他基金

EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma
EBV 介导的 AIDS 相关弥漫性大 B 细胞淋巴瘤的致癌作用
  • 批准号:
    8596646
  • 财政年份:
    2013
  • 资助金额:
    $ 12.5万
  • 项目类别:
EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma
EBV 介导的 AIDS 相关弥漫性大 B 细胞淋巴瘤的致癌作用
  • 批准号:
    8749223
  • 财政年份:
    2013
  • 资助金额:
    $ 12.5万
  • 项目类别:

相似海外基金

Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
  • 批准号:
    10467183
  • 财政年份:
    2022
  • 资助金额:
    $ 12.5万
  • 项目类别:
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
  • 批准号:
    10612928
  • 财政年份:
    2022
  • 资助金额:
    $ 12.5万
  • 项目类别:
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
  • 批准号:
    10796612
  • 财政年份:
    2022
  • 资助金额:
    $ 12.5万
  • 项目类别:
Mechanisms of Cell proliferation and tumorigenesis in ATP1A1 gene mutated adrenal cells
ATP1A1基因突变肾上腺细胞增殖及肿瘤发生机制
  • 批准号:
    21K16058
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Invesitigation of GLP-1 mediated pancreatic beta cell proliferation by interactions between islets and acinar cells
通过胰岛和腺泡细胞之间的相互作用研究 GLP-1 介导的胰腺 β 细胞增殖
  • 批准号:
    20K17516
  • 财政年份:
    2020
  • 资助金额:
    $ 12.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Engineering synthetic helper cells that autonomously deliver orthogonal IL-2 to selectively promote therapeutic T cell proliferation in tumors
工程合成辅助细胞可自主递送正交 IL-2 以选择性促进肿瘤中治疗性 T 细胞增殖
  • 批准号:
    10285941
  • 财政年份:
    2019
  • 资助金额:
    $ 12.5万
  • 项目类别:
HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells
HEG1 反应性 microRNA-23b 调节恶性间皮瘤细胞的细胞增殖
  • 批准号:
    19K07439
  • 财政年份:
    2019
  • 资助金额:
    $ 12.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Temporal information coding of cell proliferation inhibitory signal revealed by optical measurement and control of p38 activity in living cells
通过活细胞中 p38 活性的光学测量和控制揭示细胞增殖抑制信号的时间信息编码
  • 批准号:
    19K06548
  • 财政年份:
    2019
  • 资助金额:
    $ 12.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of platelet-activating factor (PAF)-associated cell proliferation in cancer and non-cancer cells.
阐明癌症和非癌细胞中血小板激活因子(PAF)相关细胞增殖的机制。
  • 批准号:
    19K10305
  • 财政年份:
    2019
  • 资助金额:
    $ 12.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of novel MMP-3 degrading products and investigation of cell proliferation using high purity odontoblast-like cells
使用高纯度成牙本质细胞样细胞鉴定新型 MMP-3 降解产物并研究细胞增殖
  • 批准号:
    15K20418
  • 财政年份:
    2015
  • 资助金额:
    $ 12.5万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了